Logo image of GNS

GENIUS GROUP LTD (GNS) Stock Fundamental Analysis

USA - NYSEARCA:GNS - SGXZ81555062 - Common Stock

0.9356 USD
+0.01 (+1.59%)
Last: 10/8/2025, 3:51:32 PM
Fundamental Rating

2

Overall GNS gets a fundamental rating of 2 out of 10. We evaluated GNS against 75 industry peers in the Diversified Consumer Services industry. The financial health of GNS is average, but there are quite some concerns on its profitability. GNS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GNS had negative earnings in the past year.
GNS had a negative operating cash flow in the past year.
GNS had negative earnings in each of the past 5 years.
In the past 5 years GNS always reported negative operating cash flow.
GNS Yearly Net Income VS EBIT VS OCF VS FCFGNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -24.62%, GNS is doing worse than 69.33% of the companies in the same industry.
With a Return On Equity value of -33.73%, GNS is not doing good in the industry: 61.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.62%
ROE -33.73%
ROIC N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
GNS Yearly ROA, ROE, ROICGNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

GNS has a worse Gross Margin (32.64%) than 62.67% of its industry peers.
GNS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for GNS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
GNS Yearly Profit, Operating, Gross MarginsGNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GNS has been increased compared to 1 year ago.
GNS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GNS has been reduced compared to a year ago.
GNS Yearly Shares OutstandingGNS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GNS Yearly Total Debt VS Total AssetsGNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that GNS is in the distress zone and has some risk of bankruptcy.
GNS has a Altman-Z score of 0.24. This is in the lower half of the industry: GNS underperforms 64.00% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that GNS is not too dependend on debt financing.
GNS has a Debt to Equity ratio of 0.14. This is in the better half of the industry: GNS outperforms 61.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC8.75%
GNS Yearly LT Debt VS Equity VS FCFGNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

GNS has a Current Ratio of 3.65. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.65, GNS belongs to the top of the industry, outperforming 90.67% of the companies in the same industry.
A Quick Ratio of 3.61 indicates that GNS has no problem at all paying its short term obligations.
GNS's Quick ratio of 3.61 is amongst the best of the industry. GNS outperforms 90.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 3.61
GNS Yearly Current Assets VS Current LiabilitesGNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

GNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.33%.
GNS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -65.69%.
Measured over the past years, GNS shows a decrease in Revenue. The Revenue has been decreasing by -4.48% on average per year.
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 38.61% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.28% on average over the next years. This is quite good.
EPS Next Y84.27%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.31%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GNS Yearly Revenue VS EstimatesGNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
GNS Yearly EPS VS EstimatesGNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GNS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNS Price Earnings VS Forward Price EarningsGNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNS Per share dataGNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

GNS's earnings are expected to grow with 38.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.61%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENIUS GROUP LTD

NYSEARCA:GNS (10/8/2025, 3:51:32 PM)

0.9356

+0.01 (+1.59%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)09-23 2025-09-23
Earnings (Next)N/A N/A
Inst Owners3.09%
Inst Owner Change0%
Ins Owners8.57%
Ins Owner ChangeN/A
Market Cap82.16M
AnalystsN/A
Price Target4.39 (369.22%)
Short Float %4.56%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-51.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.38
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.53
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.09
BVpS0.84
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.62%
ROE -33.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.64%
FCFM N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
F-Score1
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 344.67%
Cap/Sales 89.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.65
Quick Ratio 3.61
Altman-Z 0.24
F-Score1
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)138.36%
Cap/Depr(5y)102.77%
Cap/Sales(3y)32.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y84.27%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%N/A
Revenue Next Year-28.31%
Revenue Next 2Y10.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-311.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-273.5%
OCF growth 3YN/A
OCF growth 5YN/A